Insider Stock Trading History of Mccracken Joseph S


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mccracken Joseph S since year 2005. The trader's CIK number is 1632454. At the time of this reporting, Mccracken Joseph S is the Director of Nexvet Biopharma Plc . (stock ticker symbol NVET). See this page for all insider trading activities at Nexvet Biopharma Plc .

Note that in the past McCracken Joseph S also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Mccracken Joseph S since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-07-01 NVET Nexvet Biopharma Plc Option Ex 3,600 .12 450
2017-06-30 NVET Nexvet Biopharma Plc Option Ex 500 .12 62
2017-06-07 SVRA Adventrx Pharmaceuticals Inc Buy 52,250 4.75 248,187
2017-03-31 NVET Nexvet Biopharma Plc Option Ex 500 .12 62
2016-12-31 NVET Nexvet Biopharma Plc Option Ex 500 .12 62
2016-09-30 NVET Nexvet Biopharma Plc Option Ex 500 .12 62
2016-07-01 NVET Nexvet Biopharma Plc Option Ex 3,600 .12 450
2016-06-30 NVET Nexvet Biopharma Plc Option Ex 500 .12 62
2016-03-31 NVET Nexvet Biopharma Plc Option Ex 500 .12 62
2015-12-31 NVET Nexvet Biopharma Plc Option Ex 500 .12 62
2015-09-30 NVET Nexvet Biopharma Plc Option Ex 500 .12 62
2015-06-30 NVET Nexvet Biopharma Plc Option Ex 1,400 .12 175
2015-05-18 NVET Nexvet Biopharma Plc Option Ex 1,400 .12 175

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mccracken Joseph S (Director of Nexvet Biopharma Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.